glp-1 for chronic pain drugs calm inflammation beyond diabetes and weight loss Therapeutic Effects of GLP-1 Receptor

To test whether cell Barr1 deficiency affected M 3 and GLP-1 receptormediated insulin release in vivo, we injected control and -barr1-KO mice with bethanechol (2 mg/kg i.p.), a muscarinic receptor agonist, or exendin-4 (12 nmol/kg i.p.), a GLP-1 receptor agonist

10.1210/jcem.86.4.7414 41 MahapatroN.PatnaikB

10.3389/fpubh.2020.00135 8

The child shows global developmental delay, intellectual defects, severe CAs, and pyramidal signs

Kissing-loop interaction in the 3 end of the hepatitis C virus genome essential for RNA replication

So it was a progress that it at least didn't increase body weight, but had a small body weight lowering effect